Diagnostics / pathology

ESR1 Resistance Is Becoming a Treatment Pathway, Not a Footnote

A Brain Fungus Is Rising

MOGAD May Finally Have a Clue to Who Relapses

Cholangiocarcinoma Just Made FGFR2 Testing Harder to Ignore

Hepatitis A Exposed A Travel Gap.

Clearing Amyloid Is Not the Same as Saving Cognition

Cardiac Amyloidosis Has a Diagnostic Grey Zone. A New PET Tracer Could Help Close It

HER2-Mutant Lung Cancer Just Moved Into First Line

Breast Cancer Just Proved Why Biomarker Selection Matters
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
